June 20th 2013
The Prix Galien award was bestowed during the SAKK conference. The majority of Swiss oncologists were present at this.
The winner is vemurafenib, Zelboraf (Roche Pharma).
For additional information, please contact: Dr Theo
CONSTANDA, mtconstanda@medical-tribune.ch
